Form EFFECT Can-Fite BioPharma Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 31, 2026 |
| Accession Number: | 0001213900-26-036571 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H2O.ai and CAN.B Group Partner to Advance Sovereign AI in Australia
- Citi’s $82K Bitcoin Price Prediction Meets AlphaPepe’s $2.15M Presale Milestone and Faster Retail Upside Case
- Faraday Future Global CEO YT Jia Shares Weekly Investor Update: Sets Another Monthly Robotics Sales Record, Launches the EAI Robotics “Built in USA” Acceleration Program, Previews the FF “Built
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
